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Abstract
Background: Use of humidifier disinfectants (HD) at home leads to chemical airborne exposure, causing HD
associated lung injury (HDLI) with high mortality. However, the lung function in children diagnosed with HDLI is
not well studied. We investigated the effect of HD exposure on lung function, prognosis, and exposure
characteristics associated with the lung function phenotype in children.
Methods: Eighty-one children diagnosed with HDLI in a nationwide cohort were tested for spirometry and
diffusing capacity of the lung for carbon monoxide (DLco) from July 2013 and followed up with at five time points
over 2 years. The results were compared with 122 children without HD exposure as controls. Home investigation
and questionnaire analysis were conducted to assess HD inhalation exposure.
Results: HDLI survivor’s mean percent of predicted forced expiratory volume in 1 s (FEV1), forced vital capacity
(FVC), and corrected DLco were significantly lower compared with the control group. On longitudinal assessment,
FVC was within the normal range, but flattened, and spirometry showed a predominantly restrictive pattern.
Corrected DLco did not normalize above 80% despite increasing age. The persistently low phenotype of lung
function was associated with initial exposure age, especially less than 12 months of age. Higher density HD
exposure during sleep and close distance between the bed and the humidifier were significantly associated with
persistently low corrected DLco.
Conclusions: HD exposure affects prolonged decrement in lung function, especially DLco, particularly among
children who are exposed within the first year of life. These results suggested that early-life HD exposure
determines long-term prognosis of lung function in children.
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Background
Humidifier disinfectants (HD), as household chemicals, have
been used to prevent microbial growth in humidifier water
tanks since 1994 in South Korea and contain various con-
centrations of chemicals, including oligoethoxyethyl-
guanidinium chloride (PGH), polyhexamethylene-guanidine
phosphate (PHMG), and chloromethylisothiazol/methyl-iso-
thiazol (CMIT/MIT). These chemicals have been widely
used in either industrial or various consumer products, in-
cluding cosmetics, as biocides [1, 2]. However, HD inhal-
ation from a humidifier’s aerosolizer was finally identified as
a respiratory toxicant [3, 4] after an epidemic outbreak of
idiopathic childhood interstitial lung disease (chILD) charac-
terized by spontaneous air leak, rapid progression, and high
mortality among immunocompetent children in South
Korea in 2006 [5, 6]. Thereby, the novel forms of HD associ-
ated lung injury (HDLI) were defined in 2011, and HDLI
has been added in the chILD classification of exposure-
related ILD, worldwide [7, 8]. HD use in early-life was also
recently found to independently increase the risk of child-
hood asthma [9].
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Many chemical airborne exposures are associated with
a decrement in lung function in adults, including in
cases of large man-made disasters, such as the 1984
Bhopal Union Carbide methyl isocyanate gas release, the
2005 chlorine gas release from the Graniteville train ac-
cident, and current 2006 epidemic HD exposure (Add-
itional file 1: Table S1). HD inhalation causing HDLI has
been found to be characterized by restrictive lung defect
in adults [10, 11]. Despite the associations observed in
HDLI adults, the potential effects and the long-term
consequences of HDLI children on lung function have
not been explored, although children’s lungs are more
susceptible to airborne exposures than those of adults
[12, 13]. Even in case of the other chemical-related fatal-
ities, no study on lung function in children has been re-
ported. This continues to be a significant public health
issue because there is no reference on chemical-related
health crises of children, although thousands of toxic
chemicals are used worldwide. Therefore, the character-
istics of lung function and the presence of associated risk
factors after HD inhalation are important in determining
whether lung function can improve in the future in
HDLI children. Furthermore, most studies in adults
about chemical inhalants have been quantified by spiro-
metric indexes, whereas less is known about diffusing
capacity of the lung for carbon monoxide (DLco), which
is important to evaluate the alteration of small airways
after chemical exposure. Study of changes in DLco over
time is useful to follow the course of disease [14].
Therefore, we investigated the effect of inhalation ex-
posure to HD on lung function using both spirometry
and DLco. In addition, we studied the long-term prog-
nosis during childhood, which suggested the lung func-
tion phenotype and exposure characteristics associated
with the phenotype.
Methods
Study design and participants
HDLI survivors
The Korean Government completed the third round of
investigation from July 2013 to August 2016 in individ-
uals with lung disease presumed to be related to HD
exposure. Complete medical records, including demo-
graphics, laboratory findings, chest radiographs, and
computed tomography scans and/or biopsy were col-
lected. A Lung Injury Investigation Committee was
formed by pulmonologists, radiologists, and pathologists
to confirm the diagnosis of HDLI on the basis of clinical,
radiological, and pathological findings and HD exposure
assessment. Pulmonologists, radiologists, and patholo-
gists then independently assessed the records of each
case for relevant features based on diagnostic criteria
and classified the features in each area into definite,
probable, possible, or unlikely groups [15]. Thus,
independent assessments of clinical features, radio-
graphic findings, and pathology were combined to obtain
an overall assessment for each case. Subsequently, the
class of HDLI (definite, probable, possible, or unlikely)
was determined. This study analyzed subjects with defin-
ite or probable diagnoses of HDLI. The subjects were
prospectively followed in a nationwide cohort study and
underwent spirometry and DLco. We excluded pulmon-
ary function test (PFT) results that were repeated less
than 3 months after the examination.
Control group
To compare the PFT between HDLI survivors and
healthy Korean children, children as controls were re-
cruited from the outpatients of Asan Medical Center
from June 2016 through March 2018. All subjects were
born at full term and had no history of exposure to HD.
Subjects had no other diseases known to influence the
respiratory system, either directly or indirectly.
Pulmonary function testing
Spirometry and DLco were performed using Vmax229D
instrument (SensorMedics, Yorba Linda, CA, USA) ac-
cording to the American Thoracic Society (ATS)/Euro-
pean Respiratory Society (ERS) recommendations and
extrapolated to ages over 7 years [14, 16]. Reference
equations from a study by Morris et al. were used for
spirometric parameters and from Polgar et al. for DLco
[17]. We considered a percent predicted forced vital cap-
acity (FVC) less than 80% to be abnormal [18]. Patterns
of spirometry abnormality were defined as follows: nor-
mal [FEV1/FVC ≥ lower limit of normal (LLN) and
FVC ≥ LLN], restrictive, (FEV1/FVC > LLN and FVC <
LLN), obstructive (FEV1/FVC < LLN, FVC > LLN and
FEV1 < LLN), and mixed (FEV1/FVC < LLN and FVC <
LLN) [19]. Corrected DLco (adjusted for Hb, as recom-
mended by the ATS/ERS [14]) less than 80% was defined
as a significant diffusion defect [20–22]. The severity of
the corrected DLco of 60 to 80%, 40 to 60%, and less
than 40% were classified as mild, moderate, and severe
abnormalities, respectively [22].
Exposure assessment to humidifier disinfectant
The methods used for investigating use characteristics of
HD based on personal interviews and home investiga-
tions have been described in Text S1 (“exposure assess-
ment to HD”). These systematic and transparent
exposure assessment approaches used to estimate the
probability, frequency, and intensity of exposure to HD
have been used in many published epidemiologic ana-
lyses to examine the association between HD exposure
and clinically diagnosed lung disease [15, 23].
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Statistical analysis
Lung function outcomes were expressed as means with
standard errors of the estimated mean (SE). The Chi-
square or Student t-test was used to determine group dif-
ferences on variables, as appropriate. Associations be-
tween initial exposure age and lung function were
analyzed with the Cox proportional hazard regression
model adjusting for height and weight at PFT perform-
ance, HD strands, and total months of HD use and were
reported as hazard ratios (HR) with 95% confidence inter-
vals (CI). Analyses were performed using SPSS, version
24.0 (SPSS Inc., Chicago, IL, USA). Figures were generated
using GraphPad Prism 5.0 (Graphpad, San Diego, CA,
USA). P < 0.05 was considered as statistically significant.
Results
Follow-up and demographics of the study subjects
Additional file 2: Figure S1 depicts the progression of
participation in the Korean government survey. Final cri-
teria were met by 81 HDLI survivors and 122 controls.
Furthermore, 81 HDLI survivors were followed up in
five time points with a mean interval of 7.2 months for
spirometry and 6.1 months for DLco over approximately
2 years. Table 1 summarizes the study population char-
acteristics, and no discernable demographic differences
were observed between HDLI survivors and controls.
Comparison of pulmonary function test results: HDLI
survivors vs. control subjects
HDLI survivors had a significantly reduced mean per-
cent of predicted FVC, FEV1, DLco, and corrected DLco
compared with controls in both sexes of children aged
over 7 years (Table 2, total group). To determine the ac-
ceptable age to apply the normal criteria for corrected
DLco (> 80%) in children, as less than 80% of corrected
DLco was observed among girls over 7 years of age used
a controls and since we had no reference in Asian chil-
dren, we further analyzed the findings in children over 8
years and over 9 years of age (Table 2, subgroup). Con-
trols of both sexes over 8 years of age showed a greater
than 80% in corrected DLco, and the result was more
pronounced in girls over 9 years of age. The age-related
difference could be accounted for by the greater somatic
size in boys than in girls [24].
Longitudinal assessment of spirometry and DLco in HDLI
survivors
In the long-term growth characteristics of HDLI survi-
vors and control subjects, there was no apparent differ-
ence in the final growth in both spirometry and DLco
assessment in Additional file 3: Figure S2. The longitu-
dinal assessment of lung function at the five time points
in HDLI survivors compared with controls is shown in
Fig. 1. The mean percent of predicted FVC in HDLI sur-
vivors of both sexes was within the normal range during
the follow-up. However, FVC were not more than 90%
in both sexes (in detail, mean percent of predicted value
of FVC was 87.4% at 1st, 86.3% at 2nd, 87.9% at 3rd,
85.6% at 4th, and 86.2% at the 5th follow-up in boys and
84.4% at 1st, 82.4% at 2nd, 83.1% at 3rd, 83.5% at 4th,
and 81.7% at the 5th follow-up in girls) and significantly
lower compared with the control group in both sexes.
Corrected DLco was persistently reduced to less than
80% in both sexes without recovery in HDLI survivors
(boys, 74.0% in 1st, 74.3% in 2nd, 76.8% in 3rd, 74.3% in
4th, and 75.5% in the 5th follow-up; girls, 68.3% in 1st,
70.3% in 2nd, 71.3% in 3rd, 70.5% in 4th, and 74.0% in
the 5th follow-up), compared with controls, especially
Table 1 Demographics of study population
HDLI survivors (n = 81) Control group (n = 122) P-
valuemean or n (SD or %) mean or n (SD or %)
Age at spirometry (years) 8.6 (2.2) 8.7 (1.8) 0.744
Age at DLco (years) 9.3 (2.6) 8.7 (1.8) 0.085
Sex
Boy 47 (58.0) 81 (66.4) 0.226
Girl 34 (42.0) 41 (33.6)
Height (cm) at spirometry 133.5 (15.2) 133.7 (12.4) 0.925
Weight (kg) at spirometry 32.6 (14.0) 32.7 (11.5) 0.952
BMI (kg/m2) at spirometry 17.5 (3.5) 17.8 (2.9) 0.542
Height (cm) at DLco 137.6 (16.1) 133.7 (12.4) 0.064
Weight (kg) at DLco 35.9 (15.9) 32.7 (11.5) 0.123
BMI (kg/m2) at DLco 18.1 (3.8) 17.8 (2.9) 0.468
Data are presented as mean (standard deviation) or frequency (percentage) of subjects. P values for the comparison between HDLI survivors and controls
calculated with the use of the Pearson chi-square test or the Student t test, as appropriate. HDLI, HD associated lung injury; N, number; SD, standard deviation;
DLco, diffusing capacity of the lung for carbon monoxide; BMI, body mass index
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boys. The mean percent of predicted FEV1 was also
significantly lower compared with that of the control
group. The ratio of FEV1/FVC remained relatively
similar between HDLI survivors and controls within
the normal range. These results also remained signifi-
cant in FVC and corrected DLco of the z-scores from
Global Lung Function Initiative (GLI) equations in
Additional file 4: Figure S3 [25, 26].
Additional analyses of spirometry abnormalities and
severity of corrected DLco were also performed between
the initial and final tests (Fig. 2). The prevalence of a re-
strictive pattern in both the initial and final tests was re-
markable (27.2 and 40.0%, restrictively). In addition, the
proportion of low corrected DLco for the initial test was
58 (71.5%) survivors, including 47 (58.0%) with mildly
reduced DLco, 10 (12.3%) with moderated defect, and 1
(1.2%) with severe defect. At the final follow-up, 29
(67.5%) had abnormal DLco, with 26 (60.5%) mild, 2
(4.7%) moderate, and 1 (2.3%) severely low values.
Lung function phenotype of HDLI survivor associated
exposure characteristics
We classified the four prognosis phenotypes in FVC and
corrected DLco by comparing the initial and final exam-
ination as follows: (1) persistently low, (2) late decreased,
(3) improvement, and (4) normal (Fig. 3). As the late de-
creased and improvement phenotypes are mixed with
normal values, we selected the two patterns, which are
persistently low and normal, and compared the exposure
characteristics between the two phenotypes (Table 3).
Interestingly, most proportion of children with persist-
ently low lung function in both FVC and corrected DLco
has the initial exposure within the first year of the age
with statistically significant difference compared with
normal lung function (FVC, 83.3% vs. 37.0%, P = 0.008;
corrected DLco, 62.5% vs. 0.0% P = 0.020, respectively).
Among the children with exposure to HD during the
first year of life, none were in the range of normal cor-
rected DLco. These significances of initial exposure age
were also observed in the comparison between the four
prognostic phenotypes (persistently low, late decreased,
improvement, and normal) in both FVC and corrected
DLco (Additional file 1: Table S2). There is a higher pro-
portion of children with a history of fetal exposure to
HD who have a persistent decrement in lung function
compared with continued normal PFT, although with no
statistically significant difference (FVC, 16.7% vs. 3.7%,
P = 0.161; corrected DLco, 8.3% vs. 0.0%, P = 0.549,
respectively).
The airborne HD exposure intensity showed no statis-
tical difference between persistently low lung function
and normal. However, airborne HD exposure intensity
during sleep among the persistently low cases had a high
proportion of 3rd and 4th quartile compared with nor-
mal cases, showing a statistically significant difference in
corrected DLco (FVC, 50.0% vs. 37.0%, P = 0.509; cor-
rected DLco, 54.1% vs. 0.0%, P = 0.037, respectively). Dif-
ferences in the distance from the humidifier to the
sleeping place also showed a statistically significant dif-
ference in persistently low corrected DLco. Half of the
cases of persistently low corrected DLco were exposure
within 1.0 m, whereas all the subjects of the normal
Table 2 Comparison of PFT in HDLI survivors vs. control
subjects
HDLI survivors Control group P-value
n mean (SE) n mean (SE)
A. Boy, Over 7 years
FVC (% of pred) 47 87.4 (2.2) 75 98.5 (1.2) < 0.001
FEV1 (% of pred) 47 86.0 (2.0) 75 96.7 (1.3) < 0.001
FEV1/FVC 47 89.1 (0.7) 75 89.0 (0.5) 0.907
cor. DLco (% of pred) 47 74.0 (2.4) 81 87.1 (1.3) < 0.001
Girl, above 7 years
FVC (% of pred) 34 84.4 (2.2) 39 94.1 (1.4) < 0.001
FEV1 (% of pred) 34 82.4 (2.4) 39 93.5 (1.5) < 0.001
FEV1/FVC 34 90.4 (1.1) 39 91.8 (0.6) 0.256
cor. DLco (% of pred) 34 68.3 (1.9) 41 78.2 (1.8) < 0.001
B. Boy, above 8 years
FVC (% of pred) 23 83.1 (3.4) 52 98.5 (1.5) < 0.001
FEV1 (% of pred) 23 81.7 (3.1) 52 95.9 (1.6) < 0.001
FEV1/FVC 23 89.7 (1.0) 52 88.6 (0.6) 0.308
cor. DLco (% of pred) 28 74.4 (3.5) 55 89.3 (1.5) < 0.001
Girl, above 8 years
FVC (% of pred) 15 80.9 (2.3) 27 92.1 (1.5) < 0.001
FEV1 (% of pred) 15 77.3 (2.7) 27 90.4 (1.4) < 0.001
FEV1/FVC 15 89.8 (2.2) 27 91.5 (0.8) 0.465
cor. DLco (% of pred) 19 67.9 (2.0) 29 80.8 (2.3) < 0.001
C. Boy, above 9 years
FVC (% of pred) 18 81.0 (3.6) 31 98.1 (1.8) < 0.001
FEV1 (% of pred) 18 79.3 (3.0) 31 95.1 (1.9) < 0.001
FEV1/FVC 18 89.7 (1.1) 31 88.5 (0.7) 0.390
cor. DLco (% of pred) 25 74.1 (3.4) 32 89.6 (2.3) < 0.001
Girl, above 9 years
FVC (% of pred) 13 80.8 (2.6) 15 90.5 (1.7) 0.004
FEV1 (% of pred) 13 76.6 (3.0) 15 87.7 (1.4) 0.004
FEV1/FVC 13 89.2 (2.5) 15 91.3 (1.1) 0.462
cor. DLco (% of pred) 15 68.3 (2.1) 15 83.7 (2.6) < 0.001
P values for the comparison between HDLI survivors and controls calculated
with the Student t test. HDLI, HD associated lung injury; N, number; SE,
standard errors of the estimated mean; pred, predicted; FVC, forced vital
capacity; FEV1, forced expiratory volume in 1 sec; FEV1/FVC, the ratio of forced
expiratory volume in 1 sec to forced vital capacity; FEF25–75: forced expiratory
flow between 25 and 75% of vital capacity; DLco, diffusing capacity of the
lung for carbon monoxide; cor. DLco, corrected DLco
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corrected DLco were exposed to HD beyond 1.0 m. Nei-
ther HD type, total months, nor direction was associated
with abnormal lung function during long-term follow-
up. The Cox proportional hazards model for examining
the association between age on initial exposure and lung
function phenotype showed that exposure during the
first year of life significantly increased the hazard ratio
(HR) for persistently low corrected DLco [HR 1.030
(95% CI 1.001–1.060), P = 0.044] (Additional file 5: Fig-
ure S4A), but was not associated with the HR for persist-
ently low FVC (Additional file 5: Figure S4B).
Discussion
Lung function including FVC, FEV1, DLco, and cor-
rected DLco were markedly decreased in HDLI survivors
compared with controls in the cross-sectional study. In
the longitudinal assessment, FVC was found to be con-
sistently low despite being within the normal range, and
the corrected DLco was found to have no normalization
over 80% with increasing age, although no apparent dif-
ference was seen in final growth between HDLI survi-
vors and controls. Children with exposure within the
first year of life have been associated with persistently
low lung function, suggesting a critical period related to
airborne chemicals. Notably, initial exposure age under 1
year increased the hazard risk of persistent decrement in
corrected DLco adjusted for height and weight at DLco
performance, HD type, and total months of use. These
findings suggest that we may consider prolonged decre-
ment in corrected DLco as a valuable marker of lung in-
volvement in children with a history of HD exposure.
Furthermore, persistent abnormalities with corrected
DLco are also associated with higher intensity HD ex-
posure during sleep and close distance between the bed
and the humidifier. As most subjects were exposed dur-
ing sleep, the difference in airborne disinfectant expos-
ure intensity during sleep is believed to be significant.
To the best of our knowledge, this analysis is the first
to address lung function impairment and the phenotype-
associated sensitive window in relation to HD inhalation
exposure in children with a combination of case–control
and cohort designs. In addition, we confirmed the first
longitudinal lung impairment in children by chemical in-
halants and may provide guidance on evaluating lung in-
jury caused by chemical inhalation.
Many recent studies have reported that environmental
exposure in early-life affects the long-term prognosis of
respiratory disease during childhood [28, 29]. Further-
more, identification of the critical exposure window can
suggest more effective interventions for lung development
Fig. 1 Longitudinal assessment of spirometry and DLco in HDLI survivors compared with control. Figures show the mean changes in FVC (a),
FEV1 (b), FEV1/FVC (c), and corrected DLco (d) in the follow-up period, presented as the percent of the predicted values for HDLI survivors
compared to controls. Controls were compared with age- and sex-matched HDLI children both at the 1st and 5th follow-up. P-values were
calculated for the comparisons between groups for each sex using the Kruskall-Wallis test. Pred, predicted; FVC, forced vital capacity; FEV1, forced
expiratory volume in 1 sec; Cor., corrected; DLco, carbon monoxide diffusion capacity; b, boy; g, girl
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during childhood [30–32]. The present study has ad-
dressed these concerns using the association between lung
function and the use of household chemical disinfectant.
This study highlights the need for further evaluation and
continued follow-up of pulmonary function in children
with chemical inhalation during the critical period, regard-
less of the duration following the exposure.
The mechanism by which HD exposure affects pro-
longed decrement in lung function, especially corrected
DLco among children who are exposed within the first
year of life, remains unknown. Possibilities include that
HDs were dissolved in water and then dispersed into the
air by the humidifier’s aerosolizer, and the nano-sized
particles allowed them to easily reach the distal airways
causing lung injury. HDLI with pathologic findings such
as bronchiolar destruction and obliteration, centrilobular
alveolar damage, and remodeling by inflammatory may
support the above-mentioned evidence [10, 11]. Respira-
tory inhalational toxicants including irritant gases or
sensitizers have also been investigated to cause acute in-
halation injury by tissue asphyxiation including inhib-
ition of mitochondrial electron transport and oxygen use
Fig. 2 Spirometry pattern and DLco at initial and final follow-up in HDLI survivors. Figures show changes in the proportion of the spirometric
pattern (a) and severity of corrected DLco (b) between the initial and final tests in HDLI survivors. In panel A, 81 and 50 children underwent
spirometry at the 1st and 5th follow-ups, respectively. Participants showed the tendency to change to a restrictive pattern. In panel B, 81 and 43
children underwent DLco at the 1st and 5th follow-up, respectively. Most participants showed persistent decline in the diffusion defect, although
some showed improvement
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or direct airway cellular injury [33]. Additionally, in the
first 2 years of life, the alveolar volume increases with
age and somatic growth [24]. High density and close ex-
posure to HD during sleep within the first year of life
causes accelerated lung injury and disruption of alveolar
development, resulting in lower corrected DLco. As the
bronchioles, alveolar ducts, and alveolus functionally
mature at approximately 2 years of age, alterations in
these tissues could result in inappropriate distal lung de-
velopment, resulting in restrictive lung disease. An add-
itional explanation of the association between lung
function in children and HD exposure in the first year of
life [34] is that infants may spend more time at home
and may be at a high risk because they take in more of
the contaminant than adults relative to their body size,
and have particularly vulnerable physiologies, as the mi-
nute ventilation per pound in an infant is significantly
greater than that of an adult [35]. Particularly, children
breath 50% more air per kg of weight compared to adults,
and their habits are conducive to greater exposures [36].
As an infant’s room is in a relatively confined space, and
infants cannot change positions by themselves during
sleep, this can result in considerable cumulative exposure
during sleep and association between corrected DLco and
HD exposure intensity during sleep than the usual HD ex-
posure intensity in our study. These results are consistent
with those of a previous report on impulse oscillometry
abnormality in HD-exposed children [37]. Further investi-
gation is required to identify the pathophysiological mech-
anisms of this association.
Fig. 3 Prognosis phenotypes in corrected DLco and FVC over time by mean predicted %. Data for the prognosis of phenotypes in the follow-up
period in HDLI survivors are shown. Considering the significant diffusion defect to be less than 80% at each follow-up, from the 1st to 5th, the
proportion of each type of prognosis of HDLI is evaluated. HDLI children predominantly presented with abnormal lung function phenotypes
(persistently low and late decreased) with respect to the corrected DLco (67.4%) and FVC (34.0%). Bars indicate standard errors of the estimated
mean (persistently low and late decreased)
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Furthermore, a high proportion of children with a his-
tory of fetal exposure to HD showed persistent decrement
in lung function, although without statistical significance,
due to the small sample size. The placenta plays a role in
exchanging foreign molecules between the maternal and
fetal circulations, suggesting that HD may cause develop-
mental toxicity in the fetuses [38]. Future studies are re-
quired to investigate whether HD chemicals cross the
placenta and accumulate in the fetal tissues.
To date, no longitudinal research on DLco in children
has investigated the pathophysiology of chemical airborne
lung injury. DLco is an outcome of particular interest, as
exposure related lung function in asymptomatic children
without a chronic respiratory disease because exposure to
respiratory irritants is known to cause small airway disease
and affect transfer capability [39]. Impairment recovery of
corrected DLco in HD-exposed children, and association
between exposure characteristics and the corrected DLco
outcome in our study may support the above-mentioned
evidence. These findings suggest that the corrected DLco
seems to be more sensitive for detecting lung damage as
one of the alternative biomarkers of children with HDLI
and as a long-lasting indicator in lung injury after expos-
ure to HD in children. As approximately 30% of young
Korean children were exposed to HD, although without
any obvious clinical or radiologic findings, this reflects the
Table 3 Comparison of exposure characteristics based on lung function phenotype in HDLI survivors
FVC Corrected DLco
Persistently low (n = 12) Normal
(n = 27)




PHMG, only use 50.0 51.9 0.787 50.0 25.0 0.353
PGH, only use 0.0 3.7 0 0
CMIT/MIT, only use 0.0 3.7 0 0
Mixed 50.0 40.7 50.0 75.0
aHD exposure intensity/weight at exposure (%)
1st quartile 16.7 33.3 0.749 29.2 25.0 0.564
2nd quartile 33.3 25.9 20.8 50.0
3rd quartile 33.3 29.6 29.2 25.0
4th quartile 16.7 11.1 20.8 0.0
aHD exposure intensity during sleep/weight at exposure (%)
1st quartile 25.0 29.6 0.509 33.3 25.0 0.037
2nd quartile 25.0 33.3 12.5 75.0
3rd quartile 25.0 29.6 33.3 0.0
4th quartile 25.0 7.4 20.8 0.0
Age on initial exposure (%)
< 12.0 months 83.3 37.0 0.008 62.5 0.0 0.020
≥ 12.0 months 16.7 63.0 37.5 100.0
Fetal exposure (%) 16.7 3.7 0.161 8.3 0.0 0.549
Total duration of use (month) 13.7 15.9 0.690 15.7 22.9 0.466
Distance between bed and HD (%)
< 1.0 m 50.0 44.5 0.748 54.2 0.0 0.044
≥ 1.0 m 50.0 55.6 45.8 100.0
Direction dispersed into room (%)
Diagonal 41.7 44.4 0.736 37.5 25.0 0.459
Forward 33.3 40.7 41.7 25.0
Unknown 25.0 14.8 20.8 50.0
Use of HD during sleep (%) 91.7 100.0 0.129 95.8 100.0 0.678
P values for the comparison between persistently low and normal calculated with the Chi-square or Student t-test, as appropriate, in FVC and corrected DLco.
aAirborne disinfectant intensity = [bulk level of disinfectant (μg/mL) × disinfectant volume (mL) × disinfectant frequency/day × room ventilation factor]/room
volume (m3)/weight at exposure [23, 27]. FVC, forced vital capacity; DLco, diffusing capacity of the lung for carbon monoxide; N, number; HD, humidifier
disinfectants; PHMG, polyhexamethyleneguanidine phosphate; PGH, poligoethoxyethyl-guanidinium chloride; CMIT/MIT, chloromethylisothiazol/methylisothiazol
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importance of corrected DLco in the detection of latent
respiratory effects in children [40]. The measurement of
DLco in children is under investigation, with no generally
available apparatus, and we may be unable to detect po-
tential lung damage in many children. Therefore, in cases
of absence of risk factors (including chronic respiratory
disease), other than the exposure to HD in early-life, the
persistent decrement in corrected DLco in Korean school
children may imply an adverse impact of HD exposure on
the lung function.
The strengths of the present study are that this is a
well-characterized, relatively large HDLI cohort study.
The PFT result was also provided by highly skilled
leaders using a fixed standard operating procedure in a
pediatric pulmonology laboratory. Second, the study par-
ticipants are purely control subjects, in which there was
no exposure to HD compared other studies about expos-
ure to air pollution and other household chemicals. Fur-
thermore, as a lower prevalence of chronic respiratory
conditions, including smoking history, was reported in
children than in adults, HDLI survivors were considered
to be a pure disease group. Therefore, we may suggest
adequate data to make conclusions about the HD
exposure-lung function relationship.
We are aware that this study has limitations. First, we
did not perform spirometry in the event because of too
young children and severely affected patients (expired or
not performed), and thus we cannot determine whether
for some patients there was an even more severe imme-
diate decrease in lung function and subsequent incom-
plete recovery. This may have resulted in a weaker
exposure-response relationship. Second, there could be a
risk of recall bias because most characteristics on disin-
fectant use were obtained from a direct questionnaire
given to the study subjects. However, it is fairly reliable,
considering that previous studies have already reported
HDLI characteristics using this exposure data [15, 23].
Third, we could not explore the effects of exposure from
adolescence to young adulthood, and the long-term clin-
ical significance with respect to lung function is still un-
known. Considering the lung growth prognosis of
children exposed to HD, a longer follow-up is required
to investigate whether children with HDLI with an early
exposure will catch up in lung growth to peak lung func-
tion in adolescence and adulthood or will continue to
have a decline in lung function [41].
Conclusions
In conclusion, HD inhalation exposure within the first
year of life may constitute a risk to respiratory health
not only in terms of HDLI, but also as a long-term im-
pact resulting in decreased lung function in children. Al-
though the disease-specific biomarkers remain unclear,
periodic evaluation of the children using PFTs will
provide a unique opportunity to follow disease progres-
sion and to identify alternative diagnostic markers for
children with HDLI.
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